查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2040343

冠狀動脈疾病診斷影像市場規模、佔有率和趨勢分析報告：按模式、地區和細分市場預測（2026-2033 年）

Coronary Heart Disease Diagnostic Imaging Market Size, Share & Trends Analysis Report By Modality, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

冠狀動脈疾病診斷影像市場概覽

全球冠狀動脈疾病診斷（CAD）影像市場預計到 2025 年價值 46.7 億美元，預計到 2033 年將達到 77.3 億美元，2026 年至 2033 年的複合年成長率為 6.5%。

這一成長是由心血管疾病患病率上升、CT、MRI 和核成像等先進成像技術的廣泛應用以及人們對早期診斷重要性的認知提高所推動的。

此外，人口老化和生活方式相關的風險因素正在推動對精準、非侵入性診斷解決方案的需求。人工智慧整合和成像精度提升等技術進步進一步促進了市場擴張，從而改善臨床療效，並提高全球心血管疾病的診療效率。

冠狀動脈疾病診斷影像市場擴張的主要促進因素之一是全球冠狀動脈疾病發生率的上升。心血管疾病每年導致約1,980萬人死亡，仍是全球首要死因，其中冠狀動脈疾病佔很大比例。冠狀動脈疾病主要由動脈粥狀硬化引起，導致冠狀動脈狹窄或阻塞。隨著高風險患者數量的增加，對電腦斷層掃描（CT）、磁振造影（MRI）、超音波心臟超音波圖和冠動脈攝影術等診斷影像檢查技術的需求也隨之直接成長。

此外，人口結構變化，特別是人口老化，導致冠狀動脈疾病盛行率顯著上升。由於老年人更容易發生動脈粥狀硬化，因此老年族群中冠狀動脈疾病的發生率更高。例如，65歲及以上人群的盛行率顯著高於年輕人，證實了年齡是重要的危險因子。此外，隨著全球平均預期壽命的延長，慢性心血管疾病患者數量不斷增加，因此，診斷影像技術的應用也日益廣泛。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 全球冠狀動脈疾病診斷影像市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 冠狀動脈疾病診斷影像市場分析工具

第4章：冠狀動脈疾病診斷影像市場：依影像方式分類的估算與趨勢分析

  • 冠狀動脈疾病診斷影像市場：以影像方式分類的概覽
  • 冠狀動脈疾病診斷影像市場：以影像方式分類的波動分析
  • 冠狀動脈疾病診斷影像市場規模、預測和趨勢分析（按影像方式分類，2021-2033 年）
  • 電腦斷層掃描
  • X光
  • 超音波
  • 磁振造影
  • 核子醫學

第5章：冠狀動脈疾病診斷影像市場：區域估算與趨勢分析

  • 全球冠狀動脈疾病診斷影像市場：區域概覽
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭情勢

  • 公司和競爭對手的分類
    • 主要公司市佔率分析（2025 年）
    • GE Healthcare
    • Koninklijke Philips
    • Siemens Healthineers AG
    • Fujifilm Sonosite, Inc.
    • Canon Medical Systems Corporation
    • Samsung Medison Co. Ltd
    • Shimadzu Corporation
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd
    • Arineta Ltd
    • Esaote SpA
Product Code: GVR-4-68040-891-5

Coronary Heart Disease Diagnostic Imaging Market Summary

The global coronary heart disease diagnostic imaging market size was estimated at USD 4.67 billion in 2025 and is projected to reach USD 7.73 billion by 2033, growing at a CAGR of 6.5% from 2026 to 2033. Growth is driven by the rising prevalence of cardiovascular diseases, increasing adoption of advanced imaging technologies such as CT, MRI, and nuclear imaging, and growing awareness of early diagnosis.

In addition, aging populations and lifestyle-related risk factors are fueling demand for accurate and non-invasive diagnostic solutions. Technological advancements, including AI integration and improved imaging accuracy, are further supporting market expansion, enabling better clinical outcomes and enhancing the efficiency of cardiovascular disease management worldwide.

One of the main factors driving the market expansion for coronary heart disease diagnostic imaging devices is the rising incidence of coronary artery diseases (CAD) worldwide. With nearly 19.8 million deaths per year, cardiovascular diseases continue to be the leading cause of death globally, with coronary heart disease accounting for a sizable portion of these deaths. Coronary artery disease (CAD) is primarily caused by atherosclerosis, which leads to the narrowing or blockage of coronary arteries. The demand for diagnostic imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI), echocardiography, and coronary angiography have directly increased due to the increasing number of patients at risk.

Moreover, demographic changes, especially population aging, have led to a marked increase in the prevalence of CAD. The incidence of coronary conditions is higher in older populations because they are more vulnerable to atherosclerotic changes. For instance, compared to younger populations, prevalence rates are significantly higher among those over 65, underscoring age as a crucial risk factor. Furthermore, a greater number of patients have chronic cardiovascular conditions because of longer life expectancies worldwide, which has increased the use of diagnostic imaging technologies over time.

Global Coronary Heart Disease Diagnostic Imaging Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global coronary heart disease diagnostic imaging market report based on modality and region:

  • Modality Outlook (Revenue, USD Million, 2021 - 2033)
  • Computed Tomography
  • X rays
  • Ultrasound
  • Magnetic Resonance Imaging
  • Nuclear Medicine
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality Segment
    • 2.2.2. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Coronary Heart Disease Diagnostic Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of coronary artery diseases
      • 3.2.1.2. Rising adoption of early diagnostic techniques
      • 3.2.1.3. Technological advancements in cardiac imaging modalities
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of skilled radiologists
      • 3.2.2.2. High costs of medical imaging systems
  • 3.3. Coronary Heart Disease Diagnostic Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Coronary Heart Disease Diagnostic Imaging Market: Modality Estimates & Trend Analysis

  • 4.1. Coronary Heart Disease Diagnostic Imaging Market: Modality Dashboard
  • 4.2. Coronary Heart Disease Diagnostic Imaging Market: Modality Movement Analysis
  • 4.3. Coronary Heart Disease Diagnostic Imaging Market Size & Forecasts and Trend Analysis, by Modality, 2021 to 2033 (USD Million)
  • 4.4. Computed Tomography
    • 4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.5. X rays
    • 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.6. Ultrasound
    • 4.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.7. Magnetic Resonance Imaging
    • 4.7.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.8. Nuclear Medicine
    • 4.8.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Coronary Heart Disease Diagnostic Imaging Market: Regional Estimates & Trend Analysis by Country, Application, and End-use

  • 5.1. Global Coronary Heart Disease Diagnostic Imaging Market: Regional Dashboard
  • 5.2. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 5.3. North America
    • 5.3.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. U.S. market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Regulatory framework/ reimbursement structure
      • 5.3.3.3. Competitive scenario
      • 5.3.3.4. Canada market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.3.4. Mexico
      • 5.3.4.1. Key country dynamics
      • 5.3.4.2. Regulatory framework/ reimbursement structure
      • 5.3.4.3. Competitive scenario
      • 5.3.4.4. Mexico market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.4. Europe
    • 5.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 5.4.2. UK
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. UK market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. Germany market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.4.4. France
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. France market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Italy market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework/ reimbursement structure
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Spain market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework/ reimbursement structure
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Sweden market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.4.8. Norway
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework/ reimbursement structure
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Norway market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.4.9. Denmark
      • 5.4.9.1. Key country dynamics
      • 5.4.9.2. Regulatory framework/ reimbursement structure
      • 5.4.9.3. Competitive scenario
      • 5.4.9.4. Denmark market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. China market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.5.3. Japan
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. Japan market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.5.4. India
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. India market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. Australia market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Thailand market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.5.7. South Korea
      • 5.5.7.1. Key country dynamics
      • 5.5.7.2. Regulatory framework/ reimbursement structure
      • 5.5.7.3. Competitive scenario
      • 5.5.7.4. South Korea market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Brazil market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework/ reimbursement structure
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. Argentina market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.7. MEA
    • 5.7.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.7.3. South Africa
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. South Africa market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. UAE market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key country dynamics
      • 5.7.5.2. Regulatory framework/ reimbursement structure
      • 5.7.5.3. Competitive scenario
      • 5.7.5.4. Kuwait market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
    • 6.1.1. Key company market share analysis, 2025
    • 6.1.2. GE Healthcare
      • 6.1.2.1. Company overview
      • 6.1.2.2. Financial performance
      • 6.1.2.3. End-use benchmarking
      • 6.1.2.4. Strategic initiatives
    • 6.1.3. Koninklijke Philips
      • 6.1.3.1. Company overview
      • 6.1.3.2. Financial performance
      • 6.1.3.3. End-use benchmarking
      • 6.1.3.4. Strategic initiatives
    • 6.1.4. Siemens Healthineers AG
      • 6.1.4.1. Company overview
      • 6.1.4.2. Financial performance
      • 6.1.4.3. End-use benchmarking
      • 6.1.4.4. Strategic initiatives
    • 6.1.5. Fujifilm Sonosite, Inc.
      • 6.1.5.1. Company overview
      • 6.1.5.2. Financial performance
      • 6.1.5.3. End-use benchmarking
      • 6.1.5.4. Strategic initiatives
    • 6.1.6. Canon Medical Systems Corporation
      • 6.1.6.1. Company overview
      • 6.1.6.2. Financial performance
      • 6.1.6.3. End-use benchmarking
      • 6.1.6.4. Strategic initiatives
    • 6.1.7. Samsung Medison Co. Ltd
      • 6.1.7.1. Company overview
      • 6.1.7.2. Financial performance
      • 6.1.7.3. End-use benchmarking
      • 6.1.7.4. Strategic initiatives
    • 6.1.8. Shimadzu Corporation
      • 6.1.8.1. Company overview
      • 6.1.8.2. Financial performance
      • 6.1.8.3. End-use benchmarking
      • 6.1.8.4. Strategic initiatives
    • 6.1.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
      • 6.1.9.1. Company overview
      • 6.1.9.2. Financial performance
      • 6.1.9.3. End-use benchmarking
      • 6.1.9.4. Strategic initiatives
    • 6.1.10. Arineta Ltd
      • 6.1.10.1. Company overview
      • 6.1.10.2. Financial performance
      • 6.1.10.3. End-use benchmarking
      • 6.1.10.4. Strategic initiatives
    • 6.1.11. Esaote SpA
      • 6.1.11.1. Company overview
      • 6.1.11.2. Financial performance
      • 6.1.11.3. End-use benchmarking
      • 6.1.11.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 4 Global Coronary heart disease diagnostic imaging market, by Region, 2021 - 2033 (USD Million)
  • Table 5 North America Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 6 North America Coronary heart disease diagnostic imaging market, by Country, 2021 - 2033 (USD Million)
  • Table 7 U.S. Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 8 Canada Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 9 Mexico Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 10 Europe Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 11 Europe Coronary heart disease diagnostic imaging market, by Country, 2021 - 2033 (USD Million)
  • Table 12 France Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 13 Germany Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 14 Spain Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 15 Italy Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 16 UK Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 17 Norway Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 18 Denmark Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 19 Sweden Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 20 Asia Pacific Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 21 Asia Pacific Coronary heart disease diagnostic imaging market, by Country, 2021 - 2033 (USD Million)
  • Table 22 Australia Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 23 Thailand Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 24 South Korea Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 25 India Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 26 Japan Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 27 China Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 28 Latin America Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 29 Latin America Coronary heart disease diagnostic imaging market, by Country, 2021 - 2033 (USD Million)
  • Table 30 Brazil Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 31 Argentina Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 32 Middle East & Africa Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 33 Middle East & Africa Coronary heart disease diagnostic imaging market, by Country, 2021 - 2033 (USD Million)
  • Table 34 South Africa Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 35 Saudi Arabia Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 36 UAE Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)
  • Table 37 Kuwait Coronary heart disease diagnostic imaging market, by Modality, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Coronary heart disease diagnostic imaging market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Coronary heart disease diagnostic imaging market revenues, 2025 (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Coronary heart disease diagnostic imaging market Modality outlook:
  • Fig. 14 Coronary heart disease diagnostic imaging market: Modality movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global computed tomography market, 2021 - 2033 (USD Million)
  • Fig. 17 Global X rays market, 2021 - 2033 (USD Million)
  • Fig. 18 Global ultrasound market, 2021 - 2033 (USD Million)
  • Fig. 19 Global MRI market, 2021 - 2033 (USD Million)
  • Fig. 20 Global nuclear medicine market, 2021 - 2033 (USD Million)
  • Fig. 21 Regional market place: Key takeaways
  • Fig. 22 North America coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 24 Canada coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 25 Mexico coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 26 Europe coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 27 Germany coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 28 UK coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 29 France coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 30 Italy coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 31 Spain coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 32 Asia Pacific coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 33 Japan coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 34 China coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 35 India coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 36 Australia coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 37 Latin America coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 38 Brazil coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 39 MEA coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 40 South Africa coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 41 Saudi Arabia coronary heart disease diagnostic imaging market, 2021 - 2033 (USD Million)
  • Fig. 42 Market Participant Categorization
  • Fig. 43 Strategy mapping